Email this article to a friend
Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer
-
* Corresponding author: Gero Brockhoff gero.brockhoff@klinik.uni-regensburg.de
Breast Cancer Research 2009, 11:R50 doi:10.1186/bcr2339